Managing Emerging Sexual Dysfunction in Depression Treatment
Analysis compares the efficacy, tolerability, and sexual function outcomes of switching from SSRI monotherapy to vortioxetine or escitalopram monotherapy in well-treated depression patients with SSRI-induced sexual dysfunction.
June 2024